drugset / Trial / NCT07002905
A Study to Evaluate the Efficacy, Safety, and Tolerability in Participants With Obesity or Overweight With Weight-Related Comorbidities
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This randomized, double-blind, placebo-controlled phase IIa study is designed to evaluate the efficacy, safety, and tolerability of ASC30 Tablets and ASC30 Tablets A1.
Timeline
- Start
- 2025-07-03
- Primary completion
- 2025-12-08
- Completion
- 2025-12-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ASC30 | Unknown | — | Oral |
| Subject | ASC30 tablets or ASC30 tablets A1 or placebo | Unknown | — | Oral |
Indications
No indication recorded.